Edgewise Therapeutics (EWTX) Selling, General & Administrative (2020 - 2026)
Edgewise Therapeutics' Selling, General & Administrative came in at $14.4 million for Q2 2026, up 59.0% from $9.05 million a year earlier and up 25.6% from the prior quarter.
Powered by 
Analysis
Edgewise Therapeutics (EWTX) Selling, General & Administrative (2020 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Edgewise Therapeutics reported Selling, General & Administrative of $47.62 million, up 33.6% year-over-year; for FY2025, it came in at $40.02 million, up 25.6% from FY2024.
- Selling, General & Administrative has increased in each of the last five years, with a five-year compound annual growth rate of 78.5% (FY2020 to FY2025).
- Going back by year, Selling, General & Administrative was $31.87 million in FY2024 (+35.9%), $23.45 million in FY2023 (+33.1%), $17.63 million in FY2022 (+59.9%) and $11.03 million in FY2021 (+399.1%).
- The Q2 2026 figure represents the highest quarterly Selling, General & Administrative in data going back to Q1 2020.
- Year-over-year, Selling, General & Administrative has increased for 22 consecutive quarters, with growth averaging 34.8% over the last eight quarters.
- Over the past five years, the year-over-year growth in Selling, General & Administrative ranged from 13.0% (Q4 2023) to 689.1% (Q3 2021).
- Business Quant data shows EWTX's Selling, General & Administrative at $11.46 million (Q1 2026), $12.39 million (Q4 2025) and $9.38 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 3.43 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 6.43 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 3.63 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 2.90 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | -3.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | -5.65 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 1.75 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 1.92 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 3.41 Bn |
| 10 | Edgewise Therapeutics | 4.46 Bn | 4.46 Bn | - | 14.40 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 14.40 Mn |
| Mar 31, 2026 | 11.46 Mn |
| Dec 31, 2025 | 12.39 Mn |
| Sep 30, 2025 | 9.38 Mn |
| Jun 30, 2025 | 9.05 Mn |
| Mar 31, 2025 | 9.20 Mn |
| Dec 31, 2024 | 9.17 Mn |
| Sep 30, 2024 | 8.21 Mn |
| Jun 30, 2024 | 7.43 Mn |
| Mar 31, 2024 | 7.06 Mn |
| Dec 31, 2023 | 6.18 Mn |
| Sep 30, 2023 | 5.67 Mn |
| Jun 30, 2023 | 5.78 Mn |
| Mar 31, 2023 | 5.83 Mn |
| Dec 31, 2022 | 5.47 Mn |
| Sep 30, 2022 | 4.37 Mn |
| Jun 30, 2022 | 4.09 Mn |
| Mar 31, 2022 | 3.70 Mn |
| Dec 31, 2021 | 3.73 Mn |
| Sep 30, 2021 | 3.20 Mn |
API Access
Edgewise Therapeutics Selling, General & Administrative API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=EWTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "selling-general-and-administrative", "ticker": "EWTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=EWTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();